Parvovirus B19 microepidemic in renal transplant recipients with thrombotic microangiopathy and allograft vasculitis

Experimental and Clinical Transplantation

Volumn 6, Issue 2, 2008, Pages 137-143

  Ardalan, Mohammad R ^a,b   Shoja, Mohammadali M ^b,e   Tubbs, R Shane ^c   Jayne, David ^d  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

^e NONE   (Iran)

Author keywords

Parvovirus B19; Renal allograft; Transplant thrombotic microangiopathy; Vasculitis

Indexed keywords

CYCLOSPORIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RECOMBINANT ERYTHROPOIETIN;

ABDOMINAL PAIN; ACUTE GRAFT REJECTION; ADULT; ANEMIA; ARTICLE; BLOOD SMEAR; BONE MARROW BIOPSY; CHRONIC GRAFT REJECTION; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG WITHDRAWAL; EARLY DIAGNOSIS; ENDOTHELIAL DYSFUNCTION; FEMALE; FEVER; FOLLOW UP; GRAFT DYSFUNCTION; HEMODIALYSIS; HEMOGLOBIN BLOOD LEVEL; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRAN; KIDNEY BIOPSY; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LABORATORY TEST; LEUKOPENIA; LIVING DONOR; MALE; NEPHRECTOMY; PANCYTOPENIA; PARVOVIRUS INFECTION; PROTEINURIA; THROMBOCYTE COUNT; THROMBOTIC THROMBOCYTOPENIC PURPURA; VASCULITIS; WEAKNESS;

ADULT; DISEASE OUTBREAKS; FEMALE; HUMANS; IRAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; POSTOPERATIVE COMPLICATIONS; THROMBOSIS; VASCULITIS;

EID: 53649084505     PISSN: 13040855     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Egbuna O, Zand MS, Arbini A, Menegus M, Taylor J. A cluster of parvovirus B19 infections in renal transplant recipients: a prospective case series and review of the literature. Am J Transplant. 2006;6(1):225-231.
2. Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: a review of 98 cases. Clin Infect Dis. 2006;43(1):40-48.
3. Murer L, Zacchello G, Bianchi D, et al. Thrombotic microangiopathy associated with parvovirus B 19 infection after renal transplantation. J Am Soc Nephrol. 2000;11(6):1132-1137.
4. Pfrepper KI, EndersM,MotzM. Human parvovirus B19 serology and avidity using a combination of recombinant antigens enables a differentiated picture of the current state of infection. J Vet Med B Infect Dis Vet Public Health. 2005;52(7-8):362-365.
5. Banerjee A, McKane W, Thiru S, Farrington K. Wegener's granulomatosis presenting as acute suppurative interstitial nephritis. J Clin Pathol. 2001;54(10):787-789.
6. Magro CM, Crowson AN, DawoodM, Nuovo GJ. Parvoviral infection of endothelial cells and its possible role in vasculitis and autoimmune diseases. J Rheumatol. 2002;29(6):1227-1235.
7. Finkel TH, Török TJ, Ferguson PJ, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet. 1994;343(8908):1255-1258.
8. Nikkari S, Mertsola J, Korvenranta H, Vainionpää R, Toivanen P. Wegener's granulomatosis and parvovirus B19 infection. Arthritis Rheum. 1994;37(11):1707-1708.
9. Veraldi S, Mancuso R, Rizzitelli G, Gianotti R, Ferrante P. Henoch-Schönlein syndrome associated with human Parvovirus B19 primary infection. Eur J Dermatol. 1999;9(3):232-233.
10. Fukushige J, Takahashi N, Ueda K, Okada K, Miyazaki C, Maeda Y. Kawasaki disease and human parvovirus B19 antibody: role of immunoglobulin therapy. Acta Paediatr Jpn. 1995;37(6):758-760.
11. Staud R, Corman LC. Association of parvovirus B19 infection with giant cell arteritis. Clin Infect Dis. 1996;22(6):1123.
12. Díaz F, Collazos J. Glomerulonephritis and Henoch-Schoenlein purpura associated with acute parvovirus B19 infection. Clin Nephrol. 2000;53(3):237-238.
13. Gabriel SE, Espy M, Erdman DD, Bjornsson J, Smith TF, Hunder GG. The role of parvovirus B19 in the pathogenesis of giant cell arteritis: a preliminary evaluation. Arthritis Rheum. 1999;42(6):1255-1258.
14. Bilge I, Sadikoǧlu B, Emre S, Sirin A, Aydin K, Tatli B. Central nervous system vasculitis secondary to parvovirus B19 infection in a pediatric renal transplant patient. Pediatr Nephrol. 2005;20(4):529-533.
15. Brown KE, Anderson SM, Young NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science. 1993;262(5130):114-117.
16. Cooling LL, Koerner TA, Naides SJ. Multiple glycosphingolipids determine the tissue tropism of parvovirus B19. J Infect Dis. 1995;172(5):1198-1205.
17. Barsoum NR, Bunnapradist S, Mougdil A, Toyoda M, Vo A, Jordan SC. Treatment of parvovirus B-19 (B-19) infection allows for successful kidney transplantation without disease recurrence. Am J Transplant. 2002;2(5):425-428.
18. Swaminathan S, Lager DJ, Qian X, Stegall MD, Larson TS, Griffin MD. Collapsing and non-collapsing focal segmental glomerulosclerosis in kidney transplants. Nephrol Dial Transplant. 2006;21(9):2607-2614.
19. Moudgil A, Nast CC, Bagga A, et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int. 2001;59(6):2126-2133.
20. Waldman M, Kopp JB. Parvovirus B19 and the kidney. Clin J Am Soc Nephrol. 2007;2(suppl 1):S47-S56.
21. Ardalan MR. Review of thrombotic microangiopathy (TMA), and post-renal transplant TMA. Saudi J Kidney Dis Transpl. 2006;17(2):235-244.
22. Ponticelli C. De novo thrombotic microangiopathy. An underrated complication of renal transplantation. Clin Nephrol. 2007;67(6):335-340.
23. Chiurchiu C, Ruggenenti P, Remuzzi G. Thrombotic microangiopathy in renal transplantation. Ann Transplant. 2002;7(1):28-33.
24. Manzoor K, Ahmed E, Akhtar F, Kazi JI, Naqvi SA, Rizvi SA. Cyclosporine withdrawal in post-renal transplant thrombotic microangiopathy. Clin Transplant. 2006;20(1):43-47.